FAKTOR-OPTIONSSCHEIN - BIOGEN IDEC | Market Closed - Deutsche Boerse AG 20:46:36 28/06/2024 BST | ||
| 5.57 EUR | 0.00% |
|
| Current month | -3.97% | ||
| 1 month | -9.14% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 28/06/24 | 5.57 | 0.00% |
| 27/06/24 | 5.57 | -5.11% |
| 26/06/24 | 5.87 | -0.34% |
| 25/06/24 | 5.89 | +3.33% |
| 24/06/24 | 5.7 | -2.90% |
Delayed Quote Deutsche Boerse AG
Last update June 28, 2024 at 08:46 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SF1CMU |
| ISIN | DE000SF1CMU9 |
| Date issued | 11/06/2021 |
| Strike | 406.7 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.03 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 40.84 € |
|---|---|
| Lowest since issue | 2.9 € |
| Spread | 0.03 € |
| Spread % | 0.55% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
231.8
USD
Average target price
283.2
USD
Spread / Average Target
+22.14%
- Stock Market
- Certificates
- Certificat
